Private placement and issue of warrants in IDEX

To obtain funding of IDEX through 2012, the board has resolved to carry out a private placement of shares with attached warrants.

The board of directors of IDEX ASA has resolved to carry out a private placement of 9,049,103 shares. The subscription price is NOK 1.00 per share. The placement is directed towards the holders of 2011-warrants, cf. stock exchange notice 11 April 2011, but may also be directed towards larger investors, provided, however, that the offer and placement will not be directed to more than 99 participants in total. Subscription for the new shares shall take place in the period 27 April-11 May 2012. The board reserves the right to close the subscription period earlier. The placement of the shares is pursuant to authorization to issue shares, as resolved at IDEX’s 2011 annual general meeting.

The board proposes to the 2012 annual general meeting of IDEX to issue warrants. One warrant will be attached to and issued for each share issued in the placement. The warrants will have an exercise price of NOK 1.30 per share and be exercisable during the period 3 – 14 September 2012. The board may allow early exercise.

The private placement will raise equity in an amount of NOK 9 million before expenses. Including the warrants, the combined gross proceeds will be NOK 21 million.

24 April 2012

Press contact:
Ralph W. Bernstein, CEO, +47 9305 9303,

IDEX ASA is a Norwegian public company specializing in fingerprint imaging and recognition technology. IDEX’ vision is to ensure individuals a safe, secure, and user-friendly use of personal ID. IDEX has developed the award-winning SmartFinger Film technology platform including the patented fingerprint imaging principle, sensing scheme and chip design. The SmartFinger technology is available to customers under an intellectual property licensing scheme or as SmartFinger Film sensor assemblies for integration into customers’ products. For more information, please visit or contact IDEX at:

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.